Orchard Therapeutics plc — Form D
Orchard Therapeutics plc of LONDON, X0, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-23. $34.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-03-23
- Form: D
- Accession: 0001802806-23-000006
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $34.0M
- Investors: 7
- Date of first sale: 2023-03-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-476769
Issuer
- Name: Orchard Therapeutics plc
- CIK: 0001748907
- Entity type: Other
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2018
- Address: 245 HAMMERSMITH ROAD, LONDON, X0, W6 8PW
- Phone: 011-44-0-203-8088286
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Steven M Altschuler | Director | New York, NY |
| Joanne T Beck | Director | LONDON, X0 |
| John T Curnutte | Director | LONDON, X0 |
| Marc T Dunoyer | Director | LONDON, X0 |
| Bobby Gaspar | Director | LONDON, X0 |
| James A Geraghty | Director | Lexington, MA |
| Charles A Rowland, Jr. | Director | LONDON, X0 |
| Alicia A Secor | Director | LONDON, X0 |
| Bobby Gaspar | Executive Officer | LONDON, X0 |
| Frank E Thomas | Executive Officer | LONDON, X0 |
| Steven E Altschuler | Director | LONDON, X0 |
| Charles A Rowland Jr. | Director | LONDON, X0 |
| Jon T Ellis | Director | LONDON, X0 |
Other filings by this issuer (1)
More